Recurrent Colon Cancer with Liver Metastases

Video

Recurrent Colon Cancer with Liver Metastases

November 2012

  • A 51-year-old man was referred to gastroenterology for screening colonoscopy.
  • Family history includes pancreatic cancer on his father’s side and pre-menopausal breast cancer in his aunt.
  • Colonoscopy revealed a 3-cm mass, proximal to the hepatic flexure.
  • Biopsy confirmed the lesion to be of adenocarcinoma histology.
  • At the time, the patient underwent right hemicolectomy revealing a moderately differentiated tumor. Fifteen lymph nodes were removed and tested negative for metastatic disease, denoting stage T3N0M0 colon cancer.
  • The patient healed without complications and received no further treatment.

April 2015

  • The patient continued to feel well, except for occasional fatigue and diarrhea.
  • Routine evaluation showed elevated carcinoembryonic antigen.
  • PET/CT scan revealed several small lesions in multiple lobes of the liver that were PET avid
  • Biopsy was performed and confirmed the liver lesions to be metastases from colon cancer
  • The patient was referred to a local oncologist and started on infusional 5-FU and oxaliplatin (FOLFOX) in combination with bevacizumab.
  • CT scan 2 months after starting treatment showed a partial response to therapy; at 4 months the patients tumor continued to shrink
  • Oxaliplatin was discontinued; subsequently the patient received maintenance therapy with capecitabine and bevacizumab, resulting in continued disease control

February 27, 2017

  • The patient has had stable disease for 22 months and remains on bevacizumab maintenance therapy.
  • He appears generally well and free of symptoms.
Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
Related Content